This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ahmed, S. A. Articles by Sobel, B. E. Search for Related Content PubMed PubMed Citation Articles by Ahmed, S. A. Articles by Sobel, B. E.

Circulation, Vol 54, 187-193, Copyright © 1976 by American Heart Association

ARTICLES

The association of increased plasma MB CPK activity and irreversible ischemic myocardial injury in the dog

SA Ahmed, JR Williamson, R Roberts, RE Clark and BE Sobel

To evaluate the concordance between elevated plasma MB CPK and irreversible myocardial ischemic injury, coronary occlusion was induced for 10 minutes to 48 hours in 21 open chest dogs and 13 conscious animals. Results of plasma CPK and MB CPK assayed in samples obtained serially ofr 24 hours were compared to microscopic changes in hearts from the same animals examined 48 hours after occlusion. Twelve of the 34 dogs died within two hours after coronary occlusion. Among the surviving 22 dogs, one failed to exhibit gross of electrocardiographic evidence of ischemia and was therefore excluded. Twelve had coronary occlusion maintained for 30 minutes or longer and in 11 of these peak plasma MB CPK activity exceeded thenormal range (mean +/- 2 SD) and baseline values by at least 100%. Necrosis was present in the hearts from each manifested by nuclear pyknosis, eosinophilia, shrinkage of cytoplasm, and leukocytic infiltration. In the remaining nine dogs with occlusion for less than 30 minutes, peak plasma MB CPK activity was not elevated and necrosis was not detected. The close concordance between plasma MB CPK elevations and myocardial necrosis was significant (chi2 = 14.5, P less than 0.001), and thus, increased plasma MB CPK activity reflected irreversible myocardial ischemic injury.

This article has been cited by other articles:

				I. Iakovou, G. S. Mintz, G. Dangas, A. Abizaid, R. Mehran, Y. Kobayashi, A. J. Lansky, E. D. Aymong, E. Nikolsky, G. W. Stone, et al. Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1900 - 1905. [Abstract] [Full Text] [PDF]

				M. A. Costa, R. G. Carere, S. V. Lichtenstein, D. P. Foley, V. de Valk, W. Lindenboom, P. C.H. Roose, T. R. van Geldorp, C. Macaya, J. L. Castanon, et al. Incidence, Predictors, and Significance of Abnormal Cardiac Enzyme Rise in Patients Treated With Bypass Surgery in the Arterial Revascularization Therapies Study (ARTS) Circulation, November 27, 2001; 104(22): 2689 - 2693. [Abstract] [Full Text] [PDF]

				J. H. Alexander, R. A. Sparapani, K. W. Mahaffey, J. W. Deckers, L. K. Newby, E. M. Ohman, R. Corbalan, S. L. Chierchia, J. B. Boland, M. L. Simoons, et al. Association Between Minor Elevations of Creatine Kinase-MB Level and Mortality in Patients With Acute Coronary Syndromes Without ST-Segment Elevation JAMA, January 19, 2000; 283(3): 347 - 353. [Abstract] [Full Text] [PDF]

				A. Kini, J. D. Marmur, S. Kini, G. Dangas, T. P. Cocke, S. Wallenstein, E. Brown, J. A. Ambrose, and S. K. Sharma Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: Implications for early discharge after coronary intervention J. Am. Coll. Cardiol., September 1, 1999; 34(3): 663 - 671. [Abstract] [Full Text] [PDF]

				C. R. Narins, D. P. Miller, R. M. Califf, and E. J. Topol The relationship between periprocedural myocardial infarction and subsequent target vessel revascularization following percutaneous coronary revascularization: Insights from the EPIC trial J. Am. Coll. Cardiol., March 1, 1999; 33(3): 647 - 653. [Abstract] [Full Text] [PDF]

				Y. Ishikawa, J. E. Saffitz, T. L. Mealman, A. M. Grace, and R. Roberts Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma Clin. Chem., March 1, 1997; 43(3): 467 - 475. [Abstract] [Full Text] [PDF]

				A. E. Abdelmeguid, E. J. Topol, P. L. Whitlow, S. K. Sapp, and S. G. Ellis Significance of Mild Transient Release of Creatine Kinase–MB Fraction After Percutaneous Coronary Interventions Circulation, October 1, 1996; 94(7): 1528 - 1536. [Abstract] [Full Text]

				J. Darsinos, J. Karli, A. Pistevos, G. Levis, and S. Moulopoulos Hemodialysis with Calcium-Free Dialysate Prevents Myocardial Creatine Kinase Depletion After Brief Coronary Artery Occlusion in Dogs Angiology, January 1, 1988; 39(10): 865 - 872. [Abstract] [PDF]

				T. H. LEE and L. GOLDMAN Serum Enzyme Assays in the Diagnosis of Acute Myocardial InfarctionRecommendations Based on a Quantitative Analysis Ann Intern Med, August 1, 1986; 105(2): 221 - 233. [Abstract] [PDF]

				M. C. Dillon, D. F. Calbreath, A. M. Dixon, B. E. Rivin, S. F. Roark, R. E. Ideker, and G. S. Wagner Diagnostic Problem in Acute Myocardial Infarction CK-MB in the Absence of Abnormally Elevated Total Creatine Kinase Levels Arch Intern Med, January 1, 1982; 142(1): 33 - 38. [Abstract] [PDF]

				H. D. Strauss and R. Roberts Plasma MB Creatine Kinase Activity and Other Conventional Enzymes: Comparison in Patients With Chest Pain and Tachyarrhythmias Arch Intern Med, March 1, 1980; 140(3): 336 - 339. [Abstract] [PDF]

				M. A. VARAT Myocarditis of Lupus Erythematosus Ann Intern Med, March 1, 1979; 90(3): 438 - 439. [Abstract] [PDF]

				A. Ahlbom and R. Nordlander Application of Diagnostic Criteria in the Diagnosis of Myocardial Infarction Scand J Public Health, January 1, 1979; 7(2): 67 - 72. [Abstract] [PDF]

				D. D. WATERS and J. S. FORRESTER Myocardial Ischemia: Detection and Quantitation Ann Intern Med, February 1, 1978; 88(2): 239 - 250. [Abstract] [PDF]